These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16479615)

  • 1. Novel apoptosis assay to analyze immunosuppression.
    Boldt A; Barten MJ; Weiss C; Sagner A; Mohr FW; Gummert JF
    Cytometry A; 2006 Mar; 69(3):158-60. PubMed ID: 16479615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo.
    Boldt A; Barten MJ; Sagner A; Mohr FW; Adams V; Dhein S; Gummert JF
    Transplantation; 2006 Aug; 82(3):422-7. PubMed ID: 16906043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
    Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
    Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
    Barten MJ; Rahmel A; Garbade J; Bold A; Bittner HB; Dhein S; Mohr FW; Gummert JF
    Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
    Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
    Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood.
    Barten MJ; Dhein S; Chang H; Bittner HB; Tarnok A; Rahmel A; Mohr FW; Gummert JF
    J Immunol Methods; 2003 Dec; 283(1-2):99-114. PubMed ID: 14659903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of T-cell apoptosis by immunosuppressive agents.
    Takahashi K; Reynolds M; Ogawa N; Longo DL; Burdick J
    Clin Transplant; 2004; 18 Suppl 12():72-5. PubMed ID: 15217412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function.
    Barten MJ; Shipkova M; Bartsch P; Dhein S; Streit F; Tarnok A; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
    Ther Drug Monit; 2005 Apr; 27(2):123-31. PubMed ID: 15795640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.
    Puzik A; Schultz C; Iblher P; Müller-Steinhardt M; Härtel C
    Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells.
    Buron F; Perrin H; Malcus C; Héquet O; Thaunat O; Kholopp-Sarda MN; Moulin FT; Morelon E
    Transplant Proc; 2009 Oct; 41(8):3347-52. PubMed ID: 19857747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood.
    Dieterlen MT; Bittner HB; Klein S; von Salisch S; Mittag A; Tárnok A; Dhein S; Mohr FW; Barten MJ
    Cytometry B Clin Cytom; 2012 May; 82(3):151-7. PubMed ID: 22213594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans.
    Fanigliulo D; Lazzerini PE; Capecchi PL; Ulivieri C; Baldari CT; Laghi-Pasini F
    Int Immunopharmacol; 2015 Feb; 24(2):276-284. PubMed ID: 25536542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A.
    Ko H; Hambly BD; Eris JM; Levidiotis V; Wyburn K; Wu H; Chadban SJ; Yin JL
    Transpl Immunol; 2008 Nov; 20(1-2):99-105. PubMed ID: 18662782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro.
    Rumberger B; Kreutz C; Nickel C; Klein M; Lagoutte S; Teschner S; Timmer J; Gerke P; Walz G; Donauer J
    Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):283-92. PubMed ID: 19235537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
    Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
    Gummert JF; Barten MJ; Sherwood SW; van Gelder T; Morris RE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1100-12. PubMed ID: 10565830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
    Barten MJ; Garbade J; Bittner HB; Fiedler M; Dhein S; Thiery J; Mohr FW; Gummert JF
    Int Immunopharmacol; 2006 Dec; 6(13-14):2011-7. PubMed ID: 17161355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs.
    Flores MG; Zhang S; Ha A; Holm B; Reitz BA; Morris RE; Borie DC
    J Immunol Methods; 2004 Jun; 289(1-2):123-35. PubMed ID: 15251418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.